Goldman Sachs Small/Mid Cap Equity Fund Class A
GMVAX
NASDAQ
| Weiss Ratings | GMVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Reward Grade | C | |||
| Risk Index | Fair | |||
| Risk Grade | C+ | |||
| Company Info | GMVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Provider | Goldman Sachs | |||
| Manager/Tenure (Years) | Robert G. Crystal (12), Greg Tuorto (0) | |||
| Website | http://https://am.gs.com | |||
| Fund Information | GMVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Fund Name | Goldman Sachs Small/Mid Cap Equity Fund Class A | |||
| Category | Mid-Cap Blend | |||
| Sub-Category | US Equity Mid Cap | |||
| Prospectus Objective | Growth | |||
| Inception Date | Jan 31, 2014 | |||
| Open/Closed To New Investors | Open | |||
| Minimum Initial Investment | 1,000.00 | |||
| Minimum Subsequent Investment | 50.00 | |||
| Front End Fee | 0.06 | |||
| Back End Fee | -- | |||
| Dividends and Shares | GMVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield | 0.00% | |||
| Dividend | GMVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield (Forward) | 0.92% | |||
| Asset Allocation | GMVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash | 1.21% | |||
| Stock | 98.79% | |||
| U.S. Stock | 93.36% | |||
| Non-U.S. Stock | 5.43% | |||
| Bond | 0.00% | |||
| U.S. Bond | 0.00% | |||
| Non-U.S. Bond | 0.00% | |||
| Preferred | 0.00% | |||
| Convertible | 0.00% | |||
| Other Net | 0.00% | |||
| Price History | GMVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -2.17% | |||
| 30-Day Total Return | 11.71% | |||
| 60-Day Total Return | 1.74% | |||
| 90-Day Total Return | 4.58% | |||
| Year to Date Total Return | 10.54% | |||
| 1-Year Total Return | 29.47% | |||
| 2-Year Total Return | 26.97% | |||
| 3-Year Total Return | 42.61% | |||
| 5-Year Total Return | 30.55% | |||
| Price | GMVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Closing Price | -- | |||
| 1-Month Low Price | -- | |||
| 1-Month High Price | -- | |||
| 52-Week Low Price | -- | |||
| 52-Week Low Price (Date) | -- | |||
| 52-Week High Price | -- | |||
| 52-Week High Price (Date) | -- | |||
| NAV | GMVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Nav | $18.03 | |||
| 1-Month Low NAV | $16.14 | |||
| 1-Month High NAV | $18.62 | |||
| 52-Week Low NAV | $14.71 | |||
| 52-Week Low NAV (Date) | Apr 30, 2025 | |||
| 52-Week High NAV | $18.62 | |||
| 52-Week High Price (Date) | Apr 20, 2026 | |||
| Beta / Standard Deviation | GMVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.14 | |||
| Standard Deviation | 16.75 | |||
| Balance Sheet | GMVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Total Assets | 134.94M | |||
| Operating Ratios | GMVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Expense Ratio | 1.17% | |||
| Turnover Ratio | 100.00% | |||
| Performance | GMVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Last Bull Market Total Return | 27.24% | |||
| Last Bear Market Total Return | -16.32% | |||